#DRREDDY has bottomed , now will move up
We can take long position with the stop loss of 4075 and expecting Target 4500+ by August expiry
The homegrown auto major on Thursday reported a 502 percent year-on-year jump in net profit at Rs 320.54 crore for the first quarter that ended on June 30, 2022. Total income stood at Rs 6,008.71 crore during the period under review, up 52.7 percent against Rs 3,934 crore in the corresponding period of the preceding fiscal.
The drug major on Thursday reported a 108 percent year-on-year jump in net profit at Rs 1,188 crore for the first quarter ended June 30, 2022. Total income stood at Rs 5,215 crore during the period under review, up 6 percent against Rs 4,919.4 crore in the corresponding period of the preceding fiscal.
The billionaire Anil Agarwal-led company on Thursday reported a 4.7 percent year-on-year jump in consolidated net profit at Rs 4,421 crore for the first quarter that ended on June 30, 2022. The consolidated revenue from operations stood at Rs 38,251 crore, up 36 percent against Rs 28,105 crore in the corresponding period of the preceding fiscal, supported by higher sales volume across businesses, commodity prices, and strategic hedging gains.
The state-owned bank on Thursday reported a 70 percent decline in profit. The bank's total income fell to Rs 21,294 from Rs 22,515.
The Chennai-based bank reported a profit of Rs 97 crore for the first quarter ended June 2022, up from Rs 11.9 crore in the year ago period. NII (GU) was 25.9 percent up at Rs 580.6 crore up from Rs 461 crore in the corresponding period in the previous fiscal.
The company reported a 37.1 percent year-on-year decline in revenue at Rs 114.08 crore against Rs 182 crore. The revenue was up 4.6 percent at Rs 316.1 crore as compared to Rs 302.3 crore in the last fiscal.
The company reports a profit of Rs 11.45 crore in the quarter ended June against a loss of Rs 16.79 crore in the previous fiscal. The revenue stood at Rs 88.61 crore vs Rs 24.68 crore in the year ago period
The food company has signed an agreement on Thursday to acquire New Delhi-based Roadcast Tech Solutions for Rs 14.98 crore, in a all-cash deal
Bimal Dayal resigned as the Managing Director & CEO of the company.
#DRREDDY LAB: CO ANNOUNCES THE LAUNCH OF BORTEZOMIB FOR INJECTION, 3.5 MG SINGLE-DOSE VIAL IN THE U.S. MARKET ||
NOTE: BIG US SALES OF $1.2B
#DRREDDY is currently not able to cross 4630 , expecting fall till 4400,4300 so can try 4500 pe with sl 75 tgt 140,180
Please do your research before investing
DRREDDY BUY JULY CE 4600 (Intraday)
only above 100
Dr Reddy Update:-
Traders are advised to buy above 4520 levels for the upside target of 4600 and then to 4680 levels in the days to come.
Support and stop loss below 4430 on a closing basis.
#DRREDDY had a large COVID-19 portfolio and hence could be impacted this quarter. Operating costs have risen due to inflation, says Prakash Agarwal of Axis Capital
DRREDDY BUY JUNE CE 4350 (Intraday)
only above 83.5
Good News :
1. Bajaj auto going to buyback shares
2. Olema pharma going to invest in DrReddy's subsidiary
3. Abudhabi investment going to buy 20% stake in IIFL Home Finance
4. Welspun Ent going to sell Actos Highway Infra project into Rs6000 crore
1. More than 9700 corona cases come in India, more restriction expected soon
2. Private banks increase the loan rate
3. Inflation in China at 5 months high
4. Lockdown again start in China due to corona
: Chemical, Finance, Pharma and Textile stocks will go upside today
DRREDDY BUY MAY CE 4300 (Intraday)
only above 43
On May 21, the central government announced a reduction in the excise duty levied on gasoline and diesel to provide relief to consumers suffering from high fuel prices, the prime excise duty on petrol will be reduced by Rs 8 per litre, while that for diesel will be reduced by Rs 6 per litre. While the excise cut on petrol will have a revenue implication of around INR 1 Tn per year for the government
Vinidhan - The Student Investment Fund presents - The Weekly Wrap (22th May 2022)
#NIFTY50 #InvestmentIdeas #InvestingUniversity
Weekly Wrap 22 May 2022.pdf - 778 KB
DRREDDY BUY APRIL PE 4200 (Intraday)
only Above 41
STOCKS in ACTION 21 Apr
Ajanta Soya Ltd board approves stock split
Dhanvarsha Finvest allots 13,00,989 equity shares on conversion of warrants
Dr. Reddy's Laboratories announces the launch of Posaconazole Delayed-Release Tablets in the U.S. Market
Nykaa : Aveda partners with India's Leading Lifestyle Retailer, Nykaa, to launch Prestige Salons in the Country
MDL launches 6th Scorpene Sumbarine of Project-75 - VAGSHEER
Tata Steel: The company has stopped doing business with Russia. All steel manufacturing sites in India, the UK and the Netherlands are now sourcing raw material from elsewhere
L&T: India's largest engineering firm has signed a memorandum of understanding with the Indian Navy to become its knowledge partner for nurturing various technologies in electrical, weapon, engineering, machinery and control, and hull of a naval warship
Oil India: has commissioned a green hydrogen pilot plant at its Jorhat, Assam, pump station to produce 10 kg of the clean fuel per day. It has initiated a detailed study to explore blending of green hydrogen with natural gas and its effect on the existing infrastructure of Oil India
Fino Payments Bank receives RBI approval to offer FD and RD services of Suryoday Small Finance Bank
PNC Infratech received Rs. 37.0 crore early completion bonus for Purvanchal Expressway - Package VI EPC Project
Infosys completes acquisition of Digital Experience and Marketing Agency, oddity
Gland Pharmaceuticals: Nicomac Machinery is selling 20.45 lakh shares equivalent to 1.5% stake in Gland Pharma. The floor price has been set at Rs 3,118 per share. There is an option to upsize the deal
#DRREDDY #TATASTEEL #GLAND #OIL #NYKAA
Sharekhan target on DRREDDY
Price @ Call: 4373
STOCKS in ACTION 4 Apr
Nirmitee Robotics India Ltd fixes April 15, 2022 as record date for Bonus Issue
Supreme Petrochem: has received NCLT nod for reduction in paid up share capital from 94.02 crore to Rs 37.6 crore by reduction in face value from Rs 10 to Rs 4 each.
SML ISUZU to increase prices of its products by 3-4% from April 4, 2022
Jenburkt Wellness Launches D2C Brand Zixa Strong
GHCL Limited completes divestment of Home Textile business
Lupin to acquire portfolio of brands from Anglo-French Drugs & Industries Limited
Indraprastha Gas: Says Today Increased Domestic PNG Price By 16.5%
Bhageria Industries: has commissioned 4.5 MW Solar Power Projects at Ahmednagar as turnkey EPC project for a client for their captive consumption
Subex: has executed the transfer of Revenue Maximization Solution business from Subex Assurance LLP to the company
JSW Energy signs 1,000 MW Hydro Pumped Storage MoU with Govt. of Chhattisgarh
ONGC becomes the first domestic producer to join IGX as a member
NTPC declares Commercial Operation at Jetsar Solar PV Project's last part capacity of 80 MW
RMC Switchgears supplies Gas Meter shells to Genus Power Infrastructures Ltd
Blue Star inaugurates a new Medical Diagnostic Equipment Refurbishment Facility at Bhiwandi, Maharashtra
IRCTC restores 6 days a week schedule in 82902,82901 Mumbai Ahmedabad Tejas Express
Cummins India: Cummins Research and Technology, a 50:50 joint venture between the company and its US arm is voluntary liquidated. CRTIPL, as on March 31, 2021 was Rs. 279 lakhs constituting 0.059% of the consolidated net worth of the company
Sandhar Technologies: Has Secured Machining Business From TVS Motors || With The Award Of This Business Co Has Entered Into Machining For Castings Business
J B Chemicals : Azmarda brand for India to be assigned to J B Chemicals and Pharmaceuticals Ltd
Jubilant Pharmova Limited to acquire stake in Greencure
Dr. Reddy's Lab: And Medicane Health Announce Launch Of Medical Cannabis Products In Germany || Co Will Be Exclusive Distributor Of Several Of Medicane's Medical Cannabis Products In Germany
Indo Count Industries becomes the largest Global Home Textile Bedding manufacturer
TVS Motor Company's subsidiary acquires majority stake in EBCO Limited
Vaibhav Global Ltd to acquire balance stake in Vaibhav Lifestyle Ltd
Power Grid: has transferred balance 26% equity shareholding of Powergrid Vizag Transmission to PGlnvlT at a price of Rs 330.78 crore. The company has relinquished its right on additional revenue accruing to Powergrid Parli Transmission, Powergrid Warora Transmission and Powergrid Jabalpur Transmission to PGlnvlT for Rs 304.15 crore
Acrysil Ltd's UK subsidiary announces acquisition
Uttam Galva Steels: Says Section Of Employees Working At Maharashtra Plant Are On Strike From March 28
PVR: Says Has Discontinued Operations Of 23 Screens Across 9 Properties On Expiry Of Their Lease With Cineline India
GOCL Corporation Limited receives IT demand for Rs. 45.72 crores
Vascon Engineers to avail new term loan to prepay existing high cost loan
Alkem Laboratories: Says ISP Chile Had Conducted An Inspection At Co's Manufacturing Facility Located At Daman || No Observations Critical To Good Manufacturing Practices Were Detected
Future Enterprise: has defaulted on an aggregate amount of Rs 2,835.65 crore as on March 31, to a consortium of banks and lenders under the one time resolution plan
#TVSMOTOR #POWERGRID #PVR #LUPIN #DRREDDY
Stocks in News
TVS Motor Company: Subsidiary TVS Motor (Singapore) Pte. Limited has acquired a 70 percent stake in United Kingdom-based EBCO, for GBP 1,163,070. EBCO provides smart connected mobility solutions through a pipeline of e-bikes across the city and mountain biking segments. The company has tie ups with most major dealers across the United Kingdom and is the exclusive distributor of Corratec e-bikes in the UK. In addition, TVS Motor registers sales of 3.07 lakh units in March 2022, which fell compared to 3.22 lakh units sold in same month last year.
Hero MotoCorp: The company sold 4.50 lakh units of motorcycles and scooters in March 2022, declined sharply compared to 5.76 lakh units sold in corresponding month last year. In the financial year (FY22), sales dropped to 49.44 lakh units, compared to 57.91 lakh units sold in previous year.
GOCL Corporation: The company has received a notice of demand of Rs 45.72 crore from the Income Tax Department. This notice is in connection with Joint Development Agreement for the land at Kukatpally, Hyderabad, pertaining to assessment year 2013-14. But as per the company, aforesaid notice is not tenable in law.
Karnataka Bank: The bank clocked 6.27 percent growth in core deposits at Rs 80,385 crore for the year ended March 2022 compared to previous financial year, and gross advances during the same period grew by 9.5 percent to Rs 57,726 crore. The share of CASA to total deposits stands increased at 32.97 percent at March 2022, against 31.5 percent at the end of March 2021. The private sector lender expects 12 percent growth in deposits and about 17 percent in gross advances for FY23.
JSW Energy: Subsidiary JSW Neo Energy (JSWNEL) has entered into a Memorandum of Understanding with the Government of Chhattisgarh for setting up 1,000 MW capacity of hydro pumped storage project (Hasdev Bango Pumped Storage Project) in Chhattisgarh.
Alkem Laboratories: ISP Chile (Public Health Institute of Chile) had conducted an inspection at the company's manufacturing facility at Daman, India during March 28 to April 1, 2022. At the end of the inspection, no observations critical to good manufacturing practices were detected.
Lupin: The company has signed Definitive Agreement with Anglo-French Drugs & Industries for acquiring a portfolio of brands. This will strengthen the company's presence in vitamins, minerals & supplements and CNS segments.
Dr Reddy's Laboratories: The company has entered into an agreement with Novartis AG to acquire the cardiovascular brand Cidmus in India. The acquisition cost is $61 million. The Cidmus is indicated for heart failure patients with reduced ejection fraction.
#HEROMOTOCO #LUPIN #DRREDDY #TVSMOTOR #KTKBANK
GST (Goods and Services Tax) collections were settled at INR 1.42 lakh Cr for the month of March 2022 which is 6.8% up from the month of February 2022 and all time high since the implementation of GST. Increased in GST collections was result of economic recovery, anti-evasion activity and crack of fake bills.
Weekly Wrap April 3 2022.pdf - 817 KB
#AXISBANK #GAIL #DRREDDY #MacroEconomy
Nirmal Bang target on DRREDDY
Broker: Nirmal Bang
Price @ Call: 4351
great move capture in drreddy 4200CE
buy at 24 CPM 75 almost 300%
#CIPLA 1080 💥💥 What a blast
#DRREDDY Didnt triggered our levels
#SUNPHARMA 910 💥💥❤️
Cipla and sunpharma worked well Let see we are still holding for more with our trialing sl
DRREDDY BUY FEB CE 4350 (Intraday)
only above 60.5
Budget 2022 Series: Pharmaceuticals
Budget 2022 is upcoming on 1st February 2022. The market is usually turbulent on that day and presents many emotions for the investors. We, in this article, look at how government policies will impact Pharma and what to expect out of Budget’22 for them.
Nifty Pharma, over the past year, has increased by 10%. A large part of the rise was in the initial half of 2021. The second half has been tricky with USFDA checking increases, inflation affecting raw materials, and US business revenue declining. The rosy picture of Pharma had come thrashing down with a correction in the second half. They desperately need more incentives, and the Pandemic has made the Government realize their importance to the country. The Budgetary allocation to the sector increased significantly in the 2021 Budget for the same reason.
Production Linked Incentives to support the Atma Nirbhar Bharat notion has been developed for the Pharmaceutical Sector. Active Pharmaceutical Ingredients, Key Starting Materials, promotion of Bulk Drugs manufacturing are some areas focusses on. This has encouraged investment from players both domestic and international.
Industry Experts are demanding downward revision of GST Rates on clinical trials and research activities. This will help Research and Development activities to prosper. Research linked incentives where companies are incentivized to spend more on R&D, employment, and the outcome have also been considered. There needs to be an ecosystem of Research and Innovation; tax incentives may also be provided on R&D-focused funds. The weighted tax deduction on research was introduced in the 2010 Budget, which progressively came down to 100% until 2020. A reversal for the same has been lobbied for since the last budget.
Expansion of the PLI Scheme for APIs and Key starting materials, and then extending to Formulations would greatly benefit. India has been trying to benefit from the “China+1” factor and increasing API manufacturing to become closer to the goal of self-reliance in medicines. However, formulations have been left untouched for a while now. This extension would lead to incentives in the complete value chain of medicines, leading to stable supplies.
Research from Deloitte indicates expectations of tax cuts in Life-saving drugs and critical devices. Healthcare services are currently exempt from GST, but they still need to bear operational costs since the inputs or input services come under GST. A zero-rating would ensure affordable healthcare services. Moreover, tax holidays for new hospitals would encourage investment and help increase healthcare coverage in areas where the Indian Healthcare System has not been able to penetrate.
While these measures have been discussed repeatedly, it is upon the Government to prioritize and allocate their spending while keeping the fiscal deficit in control. We are in the midst of a third wave in the Pandemic; the Government should give more importance to this sector. Big Bang announcements would be well appreciated; we wait for 1st February!
#CIPLA #DRREDDY #SUNPHARMA
Top 6 Breakout Stocks for Tomorrow 03-01-2022
#BPCL #cipla #drreddy #sunpharma #techm #wipro
Yesterday's Close 4833
Today's High 4928
If Today Close Above 4910
Then More Upside Possible
Almost 100 Points Gain From Yesterday's Close In Dr Reddy